Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03695887
Other study ID # nitrousoxide
Secondary ID
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date October 1, 2019
Est. completion date December 1, 2026

Study information

Verified date November 2023
Source University of Manitoba
Contact Sarvesh Logsetty, MD
Phone 2047878682
Email logsetty@umanitoba.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Improvements in burn care have resulted in increased survival. Despite these improved outcomes one of the leading challenges of burn care remains providing adequate analgesia during routine wound care and dressing changes. The traditional use of narcotics is challenging as the therapeutic window between analgesia and suppression of breathing becomes narrow with the intense pain and high doses of narcotics needed for dressing changes.


Description:

The normal challenges of using narcotics are increased in burn patients, who have significantly altered metabolism. Unfortunately, the use of regular general anesthesia or conscious sedation is not a viable option due to the resources required, and as the hypermetabolism of burn injury would result in compromised wound healing with repeated periods of without eating related halting of nutritional intake. This has led to the use of a number of adjuncts ranging from nonmedical (virtual reality, mindfulness, hypnosis etc.) to medication (ketamine, anxiolytics etc.). Historically Nitrous oxide has been used in similar settings where severe procedural pain is of relatively shorter duration, such as tooth extraction, labor or minor surgical procedures. Nitrous oxide is a rapidly acting analgesic that takes effect seconds after inhalation, and lasts minutes. While a randomized trial of Nitrous oxide in burn care has been proposed, the only published information currently available is in a Chinese medical journal. To address this a gap in knowledge, a pilot Randomized Controlled trial is proposed to evaluate if Nitrous Oxide in the form of limited dose inhaler canisters can be used to improve pain control during burn dressing changes compared to placebo canisters.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date December 1, 2026
Est. primary completion date December 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria - adult burn patients admitted to the Health Sciences Centre - total body surface area burned of 5-20% Exclusion criteria - admitted to intensive care unit - unable to participate in the measurement outcomes (sedated, cognitively impaired, unable to understand English or visually impaired) - medical condition that precludes using nitrous oxide (respiratory disease and significant cardiovascular disease 5). - pregnant - physically unable to hold the canister - <90% SaO2 on room air - face burn - pre-injury narcotics (relative exclusion) - use of IV ketamine - pre-existing lung injury

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Nitrous Oxide Inhalant Product
Nitrous Oxide Inhalant Product
Placebo
Inactive comparator

Locations

Country Name City State
Canada University of Manitoba Winnipeg Manitoba

Sponsors (1)

Lead Sponsor Collaborator
University of Manitoba

Country where clinical trial is conducted

Canada, 

References & Publications (5)

Becker DE, Rosenberg M. Nitrous oxide and the inhalation anesthetics. Anesth Prog. 2008 Winter;55(4):124-30; quiz 131-2. doi: 10.2344/0003-3006-55.4.124. — View Citation

Gregoretti C, Decaroli D, Piacevoli Q, Mistretta A, Barzaghi N, Luxardo N, Tosetti I, Tedeschi L, Burbi L, Navalesi P, Azzeri F. Analgo-sedation of patients with burns outside the operating room. Drugs. 2008;68(17):2427-43. doi: 10.2165/0003495-200868170-00003. — View Citation

Li YX, Tang HT, Zhou WF, Hu XY, Xiao SC, Niu XH, Li YC, Wu YS, Yao M, Wang HX, Xia ZF, Zhao JJ. [Analgesic and sedative effects of inhaling a mixture of nitrous oxide and oxygen on burn patient during and after dressing change]. Zhonghua Shao Shang Za Zhi. 2013 Dec;29(6):537-40. Chinese. — View Citation

Taal LA, Faber AW, van Loey NE, Reynders CL, Hofland HW. The abbreviated burn specific pain anxiety scale: a multicenter study. Burns. 1999 Sep;25(6):493-7. doi: 10.1016/s0305-4179(99)00034-0. — View Citation

Yuxiang L, Lu T, Jianqiang Y, Xiuying D, Wanfang Z, Wannian Z, Xiaoyan H, Shichu X, Wen N, Xiuqiang M, Yinsheng W, Ming Y, Guoxia M, Guangyi W, Wenjun H, Zhaofan X, Hongtai T, Jijun Z. Analgesia effect of a fixed nitrous oxide/oxygen mixture on burn dressing pain: study protocol for a randomized controlled trial. Trials. 2012 May 24;13:67. doi: 10.1186/1745-6215-13-67. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Systolic blood pressure After administration of inhaled nitrous oxide, systolic blood pressure will be measured. 5 minute mark during burn dressing change
Other Systolic blood pressure After administration of inhaled nitrous oxide, systolic blood pressure will be measured. 10 minute mark during burn dressing change
Other Systolic blood pressure After administration of inhaled nitrous oxide, systolic blood pressure will be measured. 15 minute mark during burn dressing change
Other Systolic blood pressure After administration of inhaled nitrous oxide, systolic blood pressure will be measured. 20 minute mark during burn dressing change
Other Diastolic blood pressure After administration of inhaled nitrous oxide, Diastolic blood pressure will be measured. 5 minute mark during burn dressing change
Other Diastolic blood pressure After administration of inhaled nitrous oxide, Diastolic blood pressure will be measured. 10 minute mark during burn dressing change
Other Diastolic blood pressure After administration of inhaled nitrous oxide, Diastolic blood pressure will be measured. 15 minute mark during burn dressing change
Other Diastolic blood pressure After administration of inhaled nitrous oxide, Diastolic blood pressure will be measured. 20 minute mark during burn dressing change
Other Mean arterial pressure After administration of inhaled nitrous oxide, mean arterial pressure (mmHg) will be measured. 5 minute mark during burn dressing change
Other Mean arterial pressure After administration of inhaled nitrous oxide, mean arterial pressure (mmHg) will be measured. 10 minute mark during burn dressing change
Other Mean arterial pressure After administration of inhaled nitrous oxide, mean arterial pressure (mmHg) will be measured. 15 minute mark during burn dressing change
Other Mean arterial pressure After administration of inhaled nitrous oxide, mean arterial pressure (mmHg) will be measured. 20 minute mark during burn dressing change
Other Heart rate After administration of inhaled nitrous oxide, heart rate will be measured. 5 minute mark during burn dressing change
Other Heart rate After administration of inhaled nitrous oxide, heart rate will be measured. 10 minute mark during burn dressing change
Other Heart rate After administration of inhaled nitrous oxide, heart rate will be measured. 15 minute mark during burn dressing change
Other Heart rate After administration of inhaled nitrous oxide, heart rate will be measured. 20 minute mark during burn dressing change
Other Oxygen saturation After administration of inhaled nitrous oxide, oxygen saturation will be measured. 5 minute mark during burn dressing change
Other Oxygen saturation After administration of inhaled nitrous oxide, oxygen saturation will be measured. 10 minute mark during burn dressing change
Other Oxygen saturation After administration of inhaled nitrous oxide, oxygen saturation will be measured. 15 minute mark during burn dressing change
Other Oxygen saturation After administration of inhaled nitrous oxide, oxygen saturation will be measured. 20 minute mark during burn dressing change
Primary Burn Specific Pain Anxiety Scale The experience of the dressing change for the patient will also be assessed using the Burn specific pain and anxiety scale which consists of:
Worry about wound-healing
Fear of procedural pain
Fear of losing control because of pain
Fear of pain during dressing change
Pain severity
Keyed up because of enduring pain
Concern about wound healing
Preoccupied with pain
Tension during dressing change
Responses for each item are on a visual analogue scale ranging from "least" to "most". The response is normalized to a value between 0 and 1, representing the location selected on the line, divided by the total length of the line. The responses will be used to examine a possible relationship procedural and non procedural pain between the nurse and the patient.
1 hour before dressing change
Primary Burn Specific Pain Anxiety Scale The experience of the dressing change for the patient will also be assessed using the Burn specific pain and anxiety scale which consists of:
Worry about wound-healing
Fear of procedural pain
Fear of losing control because of pain
Fear of pain during dressing change
Pain severity
Keyed up because of enduring pain
Concern about wound healing
Preoccupied with pain
Tension during dressing change
Responses for each item are on a visual analogue scale ranging from "least" to "most". The response is normalized to a value between 0 and 1, representing the location selected on the line, divided by the total length of the line. The responses will be used to examine a possible relationship procedural and non procedural pain between the nurse and the patient.
during dressing change
Primary Burn Specific Pain Anxiety Scale The experience of the dressing change for the patient will also be assessed using the Burn specific pain and anxiety scale which consists of:
Worry about wound-healing
Fear of procedural pain
Fear of losing control because of pain
Fear of pain during dressing change
Pain severity
Keyed up because of enduring pain
Concern about wound healing
Preoccupied with pain
Tension during dressing change
Responses for each item are on a visual analogue scale ranging from "least" to "most". The response is normalized to a value between 0 and 1, representing the location selected on the line, divided by the total length of the line. The responses will be used to examine a possible relationship procedural and non procedural pain between the nurse and the patient.
1 hour after dressing change
Primary Visual Analogue Scale for pain The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("No pain") and 100 ("worst possible pain"). 1 hour before dressing change
Primary Visual Analogue Scale for pain The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("No pain") and 100 ("worst possible pain"). during dressing change
Primary Visual Analogue Scale for pain The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("No pain") and 100 ("worst possible pain"). 1 hour after dressing change
Primary Visual Analogue Scale for anxiety The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("no anxiety") and 100 ("worst possible anxiety"). 1 hour before dressing change
Primary Visual Analogue Scale for anxiety The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("no anxiety") and 100 ("worst possible anxiety"). during dressing change
Primary Visual Analogue Scale for anxiety The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("no anxiety") and 100 ("worst possible anxiety"). 1 hour after dressing change
Secondary Anxiolytic given The amount of anxiolytic given one hour prior to the dressing change. 1 hour before dressing change
Secondary Anxiolytic given The amount of anxiolytic given during the dressing change. during dressing change
Secondary Anxiolytic given The amount of anxiolytic given one hour after the dressing change. 1 hour after dressing change
See also
  Status Clinical Trial Phase
Completed NCT05023135 - DeepView SnapShot Portable (DV-SSP): Device Training Study
Completed NCT05276869 - Reliability and Feasibility of WeeFIM Instrument to Measure Functional Independence in Pediatric Burns
Completed NCT04548635 - VR for Burn Dressing Changes at Home Phase 2/Phase 3
Not yet recruiting NCT06076031 - Effects of Applying Streaming Media on Reducing Pain in Patient With Second-degree Burn During Changing Dressing N/A
Recruiting NCT05084248 - Vitamin D Deficiency in Adults Following a Major Burn Injury Phase 4
Completed NCT03113253 - TRANexamic Acid to Reduce Bleeding in BURN Surgery Phase 4
Recruiting NCT04090424 - Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT03159182 - Study of Silicone Material Inserts To Treat Burn Scars N/A
Recruiting NCT02904941 - Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns N/A
Completed NCT02681757 - Comparison of Mepitel Ag vs Antibiotic Ointment Used With Soft Cast Technique for Treatment of Pediatric Burns N/A
Recruiting NCT01812941 - Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients N/A
Completed NCT01437852 - StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns Phase 1
Completed NCT01214811 - Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing Phase 3
Completed NCT01061502 - Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds Phase 1/Phase 2
Terminated NCT00822796 - Thermogard™ Efficacy Trial N/A
Terminated NCT00824681 - Effect of Music Therapy on Families of Burn Patients Phase 1
Terminated NCT00634166 - Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group Phase 4
Terminated NCT00464386 - Continuous Glucose Monitoring (POC) in the ICU N/A
Withdrawn NCT00216983 - Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding N/A